COMPANY BACKGROUND
(as of June 2010)
The company was incorporated in December of 2006. Since the start of its operations, Xeno has been the Philippines’ fastest-growing pharmaceutical company and now ranks 8th among the national companies.

The company composed of people with a very solid background and experience in the pharmaceutical industry.  Xeno has nationwide coverage with a full complement of highly trained Territory Managers and District Managers directly reporting to Regional Managers covering Luzon, Greater Manila Area and Visayas-Mindanao regions. Xeno has a full support team for functional areas of Marketing, Regulatory Affairs and Finance. The company uses SAP (System Application & Products) for internal control.

MISSION / VISION
We seek to bring high quality healthcare with the reach of every Filipino

           We are a pharmaceutical company with a heart for the patient; a trusted partner of the medical            profession in providing world class healthcare through products and services that offer best value for            money.

We will be a premier healthcare company recognized for our world-class organization, premium products, and customer focus.

           Xeno Pharmaceuticals Phils. Inc. is a company with a strong capability to build brands. It seeks to
           engage in  a wide range of strategic partnerships with other pharmaceutical companies to build a            portfolio of  products that offer value for money to doctors and their patients.

CORPORATE OFFICERS
The initial members of the board and officers:

          Amado T Tadena                         Chairman and CEO
          Sabina Vina H Tadena                  Treasurer
          Ana Marie T Pichay                      Corporate Secretary
          Noel A Laman                              Legal Counsel

          Noel R Isberto                             Vice Chairman                            
          Josefina U De Vera                      Managing Director
          Richard M Rivera                         Sales Director
          Ephraim C Cruzado                     Finance Director
          Liza V Alivia                                Human Resources Director
          Cris J Palafox                              Regulatory Affairs Director

PRODUCTS

Xeno Pharmaceuticals Phils. Inc. & Pedia OGCare Inc. offer quality products at affordable prices for best value for money to the vast majority of the population.

With product quality as a prime factor, Xeno has carefully selected its partners by ensuring that all its products are produced at US FDA or UK MHRA accredited facilities.

Xeno has steadily increased its product offerings from an initial 5 brands in 2007 to over 20 brands in 2010. In the last 2 years, patented and differentiated products have been launched, thereby solidifying Xeno’s ability to do brand building.

In the branded generics category, Xeno has built its brands to rank in the top 3 to 5 of every Therapeutic Category it competes in.

XENO PRODUCTS

POGI PRODUCTS (pedia and OB-GYN)